Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2007
12/27/2007US20070299109 Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders
12/27/2007US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors
12/27/2007US20070299069 Methods for treating hepatitis C
12/27/2007US20070299068 viricides comprising (3-cyano-indol-2-yl)phenyl derivatives, used for for treating viral diseases and infections or for affecting viral internal ribosome entry site (IRES) activity
12/27/2007US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors
12/27/2007US20070299060 (1R,2R,3S,4S)-5-fluoro-N4-[3- methylaminocarbonylbicyclo[2.2.1]hept-5- en-2-yl)-N2-[1-methylsulfonyl-2,3- dihydroindol-5-yl]-2,4-pyrimidinediamine, used to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers
12/27/2007US20070299058 Anxiolytic Agents With Reduced Sedative And Ataxic Effects
12/27/2007US20070299057 Heterocyclic piperidines as modulators of chemokine receptor activity
12/27/2007US20070299056 Benzazepine derivatives for the treatment of neurological disorders
12/27/2007US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
12/27/2007DE102006028649A1 New 5-quinoline derivatives are topoisomerase inhibitors useful to treat bacterial infections
12/27/2007CA2655857A1 Pyrazine derivatives with extended conjugation and uses thereof
12/27/2007CA2655801A1 Therapeutic or prophylactic agent for leukemia
12/27/2007CA2655604A1 Cyclopropyl amine derivatives
12/27/2007CA2655573A1 Therapeutic or prophylactic agent for multiple sclerosis
12/27/2007CA2654689A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
12/26/2007EP1870404A1 Agent for treatment of hematopoietic tumor
12/26/2007EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1869040A1 Dna-pk inhibitors
12/26/2007EP1869031A1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor
12/26/2007EP1869020A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl
12/26/2007EP1869019A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors
12/26/2007EP1869017A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
12/26/2007EP1869006A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists
12/26/2007EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives
12/26/2007EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
12/26/2007EP1868994A1 Sulfonylpyrroles as histone deacetylase inhibitors
12/26/2007EP1539708B1 Benzimidazolones and their use as cytokine inhibitors
12/26/2007EP1525193B1 Acylaminothiazole derivatives, preparation and therapeutic use thereof
12/26/2007EP1233769B1 Imidazole derivatives
12/26/2007EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
12/26/2007CN101094848A Organic compounds
12/26/2007CN101094846A 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists
12/26/2007CN101094845A Substituted thiophenes
12/26/2007CN100357283C Methionyl aminopeptidase inhibitor
12/26/2007CN100357280C Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient
12/26/2007CN100357278C Substituted triazole diamine derivatives as kinase inhibitors
12/26/2007CN100357273C Process for the production of substituted nicotinic acid esters
12/26/2007CN100357270C D-proline derivative
12/26/2007CN100356979C Integrin expression inhibitors
12/26/2007CN100356916C Pharmaceutical compositions
12/25/2007US7312330 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
12/25/2007US7312237 Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312222 Heterocyclic piperidines as modulators of chemokine receptor activity
12/25/2007US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis
12/25/2007US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/25/2007US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
12/25/2007US7312212 Bactericides for infrections in man
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007US7312200 9-ketospinosyn derivatives
12/25/2007US7312180 Substituted 4-(4-trifluoromethylpyrazolyl)pyrimidines
12/25/2007US7312179 Cyclopropyl-thienyl-carboxamide as fungicides
12/21/2007WO2007146981A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
12/21/2007WO2007146977A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007WO2007146225A2 Heterocyclic aspartyl protease inhibitors
12/21/2007WO2007146039A2 Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide
12/21/2007WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007WO2007144174A1 Ethenyl carboxamide derivatives useful as microbiocides
12/21/2007WO2007143824A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007WO2007143823A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007WO2007143822A1 Sulfamide and sulfamate derivatives as histone deacetylase inhibitors
12/21/2007WO2007106469A3 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/21/2007WO2007099509A3 Primary amines as renin inhibitors
12/21/2007WO2007062078A3 Thrombopoietin activity modulating compounds and methods
12/21/2007WO2007059359A3 Substituted pyrazalones
12/21/2007WO2005030712A8 Thrombin receptor antagonists
12/21/2007CA2655315A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007CA2655085A1 Cgrp receptor antagonists
12/21/2007CA2654792A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007CA2654515A1 Substituted 3-cyanopyridines as protein kinase inhibitors
12/21/2007CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007CA2654098A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007CA2654097A1 Ethenyl carboxamide derivatives useful as microbiocides
12/21/2007CA2653777A1 2-anilino-4-(heterocyclic)amino-pyrimidines
12/21/2007CA2653650A1 Heterocyclic aspartyl protease inhibitors
12/20/2007US20070293546 Preparation of rosiglitazone and its salts
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade
12/20/2007US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293522 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293520 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293510 Thiadiazole compounds and use thereof
12/20/2007US20070293487 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
12/20/2007US20070293484 Thiophene Heteroaryl Amines
12/20/2007US20070293471 by reaction of 11-piperazinyldibenzo[b,f][1,4]-thiazepine with 2-(2-chloroethoxy)ethanol in presence of organic or inorganic base (such as sodium carbonate, sodium bicarbonate, potassium carbonate) under neat or aqueous condition, in presence of phase transfer catalyst (tetrabutylammonium bromide)
12/20/2007US20070293455 Silylated Carboxamides
12/20/2007US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/19/2007EP1867644A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
12/19/2007EP1867640A1 Agent for treatment of solid tumor
12/19/2007EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents
12/19/2007EP1867343A2 Novel compounds
12/19/2007EP1866316A2 Cytoskeletal active compounds, composition and use
12/19/2007EP1866304A2 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/19/2007EP1866294A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses
12/19/2007EP1866293A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 628